COMPOSITION AND METHOD OF USE FOR COMBINATIONS OF ANTI-VIRAL PROTEASE, POLYMERASE INHIBITORS AND NATURAL BIOACTIVE COMPOUNDS IN THE TREATMENT OF HEPATITIS C INFECTION

摘要

A composition and associated method for treating a hepatitis C virus (HCV) infection in a subject who is human being. The composition includes: an anti-viral agent and/or a protease inhibitor; a polymerase inhibitor; one or more viral entry inhibitors; and one or more anti-fibrotic agents and/or anti-hemolytic agents including one or more Polyphenols and/or one or more Thiols. The composition may also include one or more sulfated oligosaccharide or non-anticoagulant glycosaminoglycans (GAGs). The method administers, to the subject, a therapeutic dose of the composition to treat the subject for the HCV infection.